Key result
Early cardiac index improvement post-Impella 5.5 is linked to eGFR recovery at 72 hours.
Why the study?
Temporary mechanical circulatory support with Impella 5.5 may unmask reversible renal dysfunction in advanced HF, and early identification of renal recovery could impact transplant strategy. Whether short-term changes in invasive hemodynamics during Impella 5.5 support are associated with renal function recovery needed evaluation.
Do short-term changes in invasive hemodynamics during Impella 5.5 support improve estimated glomerular filtration rate at 72 hours in heart failure patients bridged to transplant?
Cohort (n=61)
Do short-term changes in invasive hemodynamics during Impella 5.5 support improve estimated glomerular filtration rate at 72 hours in heart failure patients bridged to transplant?
Dynamic hemodynamic response at 72 hours after Impella 5.5 implantation, particularly improvement in cardiac index, is independently associated with eGFR improvement and may serve as a marker of reversible cardiorenal physiology in heart failure patients bridged to transplant.
Background Renal dysfunction in advanced heart failure (HF) patients critically influences heart transplant eligibility and the choice between heart-only transplantation and simultaneous heart-kidney transplantation (SHKT). In many patients, kidney injury reflects potentially reversible cardiorenal syndrome driven by hemodynamic derangements, particularly elevated venous congestion, rather than intrinsic renal disease. Temporary mechanical circulatory support (tMCS) devices, such as the Impella 5.5, offers rapid hemodynamic stabilization and may unmask reversible renal dysfunction. Early identification of renal recovery during support could meaningfully impact transplant strategy. Purpose To evaluate whether short-term changes in invasive hemodynamics during Impella 5.5 support are associated with renal function recovery. Methods We retrospectively analyzed patients with HF supported with Impella 5.5 as bridge-to-transplant. Invasive hemodynamics and renal function were assessed at baseline and 72 hours post-Impella 5.5 implantation. The primary outcome was the change in estimated Glomerular Filtration Rate (ΔeGFR). Univariate and multivariate linear regression analyses evaluated associations between ΔeGFR and changes in Cardiac Index (ΔCI), Pulmonary Artery Pulsatility index (ΔPAPi), Stroke Volume (ΔSV), Mean Arterial Pressure (ΔMAP), and Right Atrial Pressure (ΔRA), adjusting for baseline clinical characteristics. Results The study cohort included 61 patients supported with Impella 5.5 with complete pre- and post-Impella hemodynamic profiles. The majority were male (80.3%), white (58.3%), and 57.4% had hypertension. The median baseline eGFR was 47 mL/min/1.73 m² (27-63). On univariate analysis, ΔGFR was positively associated with ΔCI (β 8.17, p=0.002), ΔPAPi (β 0.86, p=0.020), and ΔSV (β 0.22, p=0.032), but not with ΔMAP or ΔRA (Table 1). In multivariate hemodynamic modeling, both ΔCI (β 13.29, p=0.011) and ΔPAPi (β 0.72, p=0.036) remained independently associated with renal recovery (model R²=0.24) (Table 2). However, in fully adjusted analyses incorporating baseline clinical characteristics, ΔCI emerged as the dominant predictor (β 15.44, p=0.005), whereas baseline hypertension attenuated renal recovery (β −9.80, p=0.023). Other pressure-based indices were not independently predictive. The final model demonstrated moderate explanatory power (R²=0.321, p=0.0066). Additionally, to evaluate potential effect modification, we tested the interaction between ΔCI and baseline hypertension (Table 3). We found no evidence of effect modification by baseline hypertension. Conclusion Collectively, these data reinforce the concept that dynamic hemodynamic response at 72 hours, particularly improvement in cardiac index, may serve as a biologically meaningful marker of reversible cardiorenal physiology and may help inform transplant strategy and timing decisions.
No takes yet. Share an insight, caveat, or question.
Desai et al. (2026) conducted a cohort in Advanced heart failure bridged to transplant (n=61). Impella 5.5 support and short-term invasive hemodynamic changes (ΔCI, ΔPAPi, ΔSV, ΔMAP, ΔRA) vs. Baseline pre-Impella hemodynamic and renal profiles was evaluated on Change in estimated Glomerular Filtration Rate (ΔeGFR) at 72 hours post-Impella 5.5 implantation (β 15.44 (for ΔCI in fully adjusted model), p=0.005). Change in cardiac index at 72 hours post-Impella 5.5 implantation independently predicted eGFR recovery (β 15.44, p=0.005), whereas baseline hypertension attenuated recovery (β −9.80, p=0.023).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: